DK1056467T3 - Metode til behandling af sygdomme eller lidelser i det indre øre - Google Patents

Metode til behandling af sygdomme eller lidelser i det indre øre

Info

Publication number
DK1056467T3
DK1056467T3 DK99910259T DK99910259T DK1056467T3 DK 1056467 T3 DK1056467 T3 DK 1056467T3 DK 99910259 T DK99910259 T DK 99910259T DK 99910259 T DK99910259 T DK 99910259T DK 1056467 T3 DK1056467 T3 DK 1056467T3
Authority
DK
Denmark
Prior art keywords
inner ear
sensory cells
disorders
cells
cyclin
Prior art date
Application number
DK99910259T
Other languages
Danish (da)
English (en)
Inventor
Hubert Loewenheim
Original Assignee
Sound Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sound Pharmaceuticals Inc filed Critical Sound Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1056467T3 publication Critical patent/DK1056467T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99910259T 1998-02-23 1999-02-23 Metode til behandling af sygdomme eller lidelser i det indre øre DK1056467T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19807426A DE19807426A1 (de) 1998-02-23 1998-02-23 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs
PCT/EP1999/001153 WO1999042088A2 (de) 1998-02-23 1999-02-23 Verfahren zur behandlung von erkrankungen oder störungen des innenohrs

Publications (1)

Publication Number Publication Date
DK1056467T3 true DK1056467T3 (da) 2004-02-09

Family

ID=7858563

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99910259T DK1056467T3 (da) 1998-02-23 1999-02-23 Metode til behandling af sygdomme eller lidelser i det indre øre

Country Status (11)

Country Link
US (1) US7087581B1 (enExample)
EP (1) EP1056467B1 (enExample)
JP (1) JP2002503687A (enExample)
AT (1) ATE250936T1 (enExample)
AU (1) AU763868B2 (enExample)
CA (1) CA2320717C (enExample)
DE (2) DE19807426A1 (enExample)
DK (1) DK1056467T3 (enExample)
ES (1) ES2211055T3 (enExample)
PT (1) PT1056467E (enExample)
WO (1) WO1999042088A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2325198A1 (en) 1999-06-01 2011-05-25 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
CA2412764C (en) * 2000-07-11 2014-06-03 Sound Pharmaceuticals Incorporated Stimulation of cellular regeneration and differentiation in the inner ear
JP4533144B2 (ja) 2002-10-02 2010-09-01 アンジェスMg株式会社 聴覚機能障害用医薬
EP1585523B1 (en) * 2002-12-17 2008-10-01 Centre National De La Recherche Scientifique (Cnrs) Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness
EP2293800B1 (en) 2008-06-06 2016-10-05 Quark Pharmaceuticals, Inc. Compositions and methods for treatment of ear disorders
DE102010007281A1 (de) * 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
RU2480195C1 (ru) * 2011-11-02 2013-04-27 Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава РФ") Способ лечения заболеваний внутреннего уха
EP2802657B1 (en) 2012-01-12 2018-05-02 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
WO2013134022A1 (en) * 2012-03-05 2013-09-12 Wake Forest University Health Sciences Regeneration of inner ear cells
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528388A1 (de) * 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
EP0866716A4 (en) 1995-11-13 2002-05-02 Cambridge Neuroscience Inc METHOD FOR TREATING DISORDERS OF THE NON-VISUAL SENSORIC EPITHEL
US5962224A (en) * 1995-12-19 1999-10-05 Dana-Farber Cancer Institute Isolated DNA encoding p62 polypeptides and uses therefor
AU3591597A (en) 1996-06-28 1998-01-21 Regents Of The University Of California, The Transformation and genetherapy of cells of the inner ear
AU4600297A (en) 1996-09-27 1998-04-17 Trustees Of The University Of Pennsylvania, The Novel methods for inducing proliferation in auditory receptor epithelium
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product

Also Published As

Publication number Publication date
WO1999042088A3 (de) 2000-03-02
EP1056467A2 (de) 2000-12-06
CA2320717C (en) 2009-03-24
WO1999042088A2 (de) 1999-08-26
DE59907195D1 (de) 2003-11-06
ES2211055T3 (es) 2004-07-01
AU2928199A (en) 1999-09-06
ATE250936T1 (de) 2003-10-15
PT1056467E (pt) 2004-02-27
DE19807426A1 (de) 1999-10-14
CA2320717A1 (en) 1999-08-26
US7087581B1 (en) 2006-08-08
AU763868B2 (en) 2003-07-31
JP2002503687A (ja) 2002-02-05
EP1056467B1 (de) 2003-10-01

Similar Documents

Publication Publication Date Title
PA8478501A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa
NO20000841L (no) N-Aroylfenylalanin-derivater
EP1140840A4 (en) -G (V) -CARBOXYARYL SUBSTITUTED DIPHENYL UREASINE AS RAF KINASE INHIBITORS
DE60331479D1 (de) Pyrimidin-derivate zur behandlung von anormalem zellwachstum
DK1056467T3 (da) Metode til behandling af sygdomme eller lidelser i det indre øre
ATE288431T1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
NO20023085D0 (no) Ikke-peptidyl inhibitorer av VLA-4 avhengig cellebinding nyttig for behandling av inflammatoriske, autoimmune ogrespiratoriske sykdommer
NO20052864L (no) Nye hydroksyindoler, deres anvendelse som fosfordiesterase 4 inhibitorer samt fremstilling av forbindelser
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
DE602004013792D1 (de) Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes
ATE495187T1 (de) Dalda-analoge und ihre verwendung
DK1228032T3 (da) Præparater, som indeholder hydroxyicosatetraensyrederivater, og fremgangsmåder til anvendelse ved behandling af öjentörhedslidelser
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
NO20014529D0 (no) Tetrahydropyranderivater og deres anvendelse som terapautiske midler
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
DE60019318D1 (de) Zusammensetzungen und verfahren zur inhibierung vom zellulären g2-übergang und sensitisierung von zellen gegen dna-schädigenden wirkstoffe
NO20003694L (no) VLA-4 antagonister
NO20010654D0 (no) Ny anvendelse av taxoidderivater
ATE460166T1 (de) Chinazolinderivate und ihre verwendung bei der behandlung von thrombocythämie
PT1000046E (pt) Derivados de piperazina activos no trato urinario inferior
EP2016944A3 (en) Angiogenesis inhibitor containing a derivative of rifampicin
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
RU98109220A (ru) Способ лечения экземы